Ghana and Gambia confront hepatitis B crisis as cases rise

Health officials in Ghana warn that about three million people live with chronic hepatitis B, yet only around one percent have been diagnosed and an even smaller fraction receives treatment. Deaths from hepatitis B increased from 15,443 in 2024 to roughly 16,000 in 2025. The Ghana Health Service aims to meet WHO targets of diagnosing 90% of chronic cases and treating 80% by 2030, emphasizing a nationwide birth‑dose vaccination programme to curb mother‑to‑child transmission.

In The Gambia, experts report a surge in severe liver disease among young people under 30, despite years of vaccination efforts. More than 100 new liver‑cancer cases are diagnosed each year, and over 2,000 deaths from hepatitis‑related complications have occurred since 2012. Researchers cite gaps in vaccination coverage, public awareness, and access to testing and treatment as key obstacles. Both countries highlighted the need for stronger public education, expanded screening, and sustained investment during World Hepatitis Day events.